Misconduct Inquiry

Dan L. Burk, law professor at Seton Hall University, wrote ("Legal Process Presented In Ryan Report Requires Reconsideration," The Scientist, Sept. 16, 1996, page 9), "To that end, the major focus of misconduct inquiry by the scientific community will be to determine the empirical demonstrability of a researcher's claims, to purge the record of fabricated or incorrect data, and to discourage future conduct that would tend to corrupt the acquisition of certified knowledge" (emphasis added). The

Written byCharles Mccutchen
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Dan L. Burk, law professor at Seton Hall University, wrote ("Legal Process Presented In Ryan Report Requires Reconsideration," The Scientist, Sept. 16, 1996, page 9), "To that end, the major focus of misconduct inquiry by the scientific community will be to determine the empirical demonstrability of a researcher's claims, to purge the record of fabricated or incorrect data, and to discourage future conduct that would tend to corrupt the acquisition of certified knowledge" (emphasis added). The part in italics is weird and unlikely to happen. It would make it legitimate to invent data if one guessed right, and a crime to publish results that cannot be replicated, even if the reason were innocent error by the author or the attempting replicator.

The question scientists ask about misconduct are those asked about any sort of fakery. Was the work actually done? Was it done as described? Was it done by its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies